20 (AIDX) Preferred Shares (2024 - 2025)
20 (AIDX) posted Preferred Shares of $14715.0 for Q4 2025, up 125.86% on a QoQ basis from $6515.0 in Q4 2024, and up 125.86% year-over-year from $6515.0 in Q4 2024.
20 (AIDX) Preferred Shares (2024 - 2025) Analysis & Trends
20's Preferred Shares history runs 2 years deep, the most recent figure standing at $14715.0 for Q4 2025.
- Quarterly Preferred Shares rose 125.86% year-over-year to $14715.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14715.0 (up 125.86% YoY) and the FY2025 annual result came in at $14715.0, up 125.86% from the prior year.
- Preferred Shares was $14715.0 for Q4 2025 at 20, up from $6515.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $14715.0 in Q4 2025 and bottomed at $6515.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | 20 | 3.91 Mn | -313,912.28 | 62,884.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,715.00 |
| Dec 31, 2024 | 6,515.00 |